Clinical Trials Directory

Trials / Completed

CompletedNCT02664324

MSPT Device Usability Study

The Multiple Sclerosis Performance Test (MSPT) Device for Functional Assessment of Multiple Sclerosis (MS) Patients

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Biogen · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this feasibility study is to evaluate the functionality (e.g., as defined by the primary endpoints) of the fully integrated Multiple Sclerosis Performance Test (MSPT) device, when used by unsupervised participants with MS, or related conditions, with a broad range of disability, in multi-clinical-care environments. Secondary objectives include: Participant perception of usability of device; Participant satisfaction with the device; Ascertain the impact of different clinical environments on device usability; Ascertain impact of assistive devices in usability of device; Ascertain functionality of Bluetooth remote as compared with manual timing.

Detailed description

This study does not involve evaluation(s) of the clinical efficacy of the MSPT device or the efficacy of MS therapies. This feasibility study is examining the usability of the fully integrated MSPT device. Study participants will be enrolled for same-day testing.

Conditions

Timeline

Start date
2016-03-01
Primary completion
2016-04-01
Completion
2016-04-01
First posted
2016-01-27
Last updated
2016-05-04

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02664324. Inclusion in this directory is not an endorsement.

MSPT Device Usability Study (NCT02664324) · Clinical Trials Directory